Article
The impact of Bevacizumab on mucosal healing after dental extraction in patients undergoing cancer treatment in the central region of Algeria
2024-01-05
Abstract excerpt
<title>Abstract</title> <p><bold>Objectives:</bold> Bevacizumab currently stands as the most prescribed anti-VEGF medication in oncology. It functions as an angiogenesis inhibitor, thereby slowing down tumor progression. However, this drug is associated with side effects both in general health and in the oral cavity. To assess the impact of Bevacizumab on mucosal healing after dental extraction in patients underg...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bb3fe35d-8d88-514b-b24e-05bb49b96428
- DOI
- 10.21203/rs.3.rs-3689262/v1
